Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a ...

Brookstone Capital Management lifted its holdings in KeyCorp (NYSE:KEY – Free Report) by 6.3% in the fourth quarter, ...

The broader Topix index settled 1.19 percent higher at 2,711.27. Automakers led the surge, with Honda Motor rising 1.4 percent while Toyota Motor and Subaru both gained around 3 percent.

Most Asian stocks rose on Monday after major U.S. stock indexes rallied to close out their best week in two months Friday on ...

Magnificent Seven stocks. Big Tech's runaway growth created gains, but headwinds are forming and some observers doubt the Mag ...

The People's Bank of China has announced that it would leave key interest rates unchanged. Following a meeting of the Monetary Policy Committee, a decision was made by the central bank to maintain its ...

Daichi Fujii from the Hiratsuka City Museum in Japan captured a meteor impact the moon with multiple telescopes. Credit: ...

Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...

A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...

The current price of Dai (DAI) is $0.999982, as of January 18, 2025. Over the last 24 hours, the price has moved by -0.01%, with a change of 0.02% in the past hour. For longer-term performance, the ...